New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 15, 2013
10:12 EDTANGI, APA, ECA, EADSY, LINE, ICE, CSTR, GM, TROW, CTL, UGI, RIG, STI, CMA, DVA, END, EXR, HBAN, LOGM, MWW, GOLD, STJ, RDYOn the Fly: Analyst Downgrade Summary
Today’s noteworthy downgrades include: Angie's List (ANGI) downgraded to Market Perform from Outperform at Barrington... Comerica (CMA) downgraded to Sell from Neutral at Citigroup... DaVita (DVA) downgraded to Neutral from Buy at Goldman... Endeavour (END) downgraded to Hold from Buy at C.K. Cooper... Extra Space Storage (EXR) downgraded to Sell from Neutral at UBS... Gold Fields (GFI) downgraded to Sector Underperformer from Sector Performer at CIBC... Huntington Bancshares (HBAN) downgraded to Neutral from Buy at Citigroup... LogMeln (LOGM) downgraded to Neutral from Overweight at JPMorgan... Monster Worldwide (MWW) downgraded to Neutral from Buy at SunTrust... Randgold Resources (GOLD) downgraded to Sell from Neutral at Citigroup... St. Jude Medical (STJ) downgraded to Underperform from Neutral at Cowen... SunTrust (STI) downgraded to Hold from Buy at Jefferies... Transocean (RIG) downgraded to Sell from Hold at Deutsche Bank... UGI Corporation (UGI) downgraded to Neutral from Buy at UBS... Apache (APA) downgraded to Neutral from Outperform at Macquarie... Encana (ECA) downgraded to Neutral from Buy at UBS... EADS (EADSY) downgraded to Market Perform from Outperform at Bernstein... LINN Energy (LINE) downgraded to Sector Perform from Outperform at Howard Weil... IntercontinentalExchange (ICE) downgraded to Neutral from Buy at Compass Point... Coinstar (CSTR) downgraded to Neutral from Buy at Compass Point... General Motors (GM) downgraded to Hold from Buy at Craig-Hallum... T. Rowe Price (TROW) downgraded to Neutral from Positive at Susquehanna... CenturyLink (CTL) downgraded to Hold from Buy at Argus... Dr. Reddy's Labs (RDY) downgraded to Neutral from Buy at BofA/Merrill.
News For ANGI;CMA;DVA;END;EXR;HBAN;LOGM;MWW;GOLD;STJ;STI;RIG;UGI;APA;ECA;EADSY;LINE;ICE;CSTR;GM;TROW;CTL;RDY From The Last 14 Days
Check below for free stories on ANGI;CMA;DVA;END;EXR;HBAN;LOGM;MWW;GOLD;STJ;STI;RIG;UGI;APA;ECA;EADSY;LINE;ICE;CSTR;GM;TROW;CTL;RDY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
August 7, 2014
15:43 EDTGOLDRandgold downgraded to Sector Perform from Outperform at Scotia Capital
Subscribe for More Information
13:55 EDTRDYTeva won't be meaningfully hurt soon by new Copaxone filing, says BMO Capital
After Teva (TEVA) confirmed that it received the first paragraph IV notice for the 3x per week version of its Copaxone drug from Dr. Reddy's (RDY), BMO Capital said it had expected companies to seek to market a generic version of the latest Copaxone formulation, but was surprised that Dr. Reddy's took this action. The firm notes that Teva's decision to file a lawsuit against Dr. Reddy over the application will trigger a 30 month stay of approval of the generic version,. BMIO Capital says that investors should keep this issue on their radar, but the firm does not expect Teva to be meaningfully hurt in the near-term by this development. It keeps an Outperform rating on Teva.
12:06 EDTRDYTeva will continue to defend COPAXONE intellectual property rights
Teva (TEVA) confirmed that it has received the first paragraph IV notice for its three-times-a-week COPAXONE 40 mg/mL product from Dr. Reddy’s Laboratories (RDY). Teva will continue to vigorously defend its COPAXONE intellectual property rights against infringement wherever they are challenged. Teva intends to file a lawsuit for patent infringement against Dr. Reddy’s within the 45 day period provided under the Hatch-Waxman Act. The filing of the lawsuit will trigger a 30 month stay of FDA approval of Dr. Reddy’s ANDA. COPAXONE 40 mg/mL is protected by two Orange Book patents that expire in 2030.
10:21 EDTRIGTransocean says pace of tendering is slow for deep water market
Subscribe for More Information
09:08 EDTRIGOn The Fly: Pre-market Movers
Subscribe for More Information
08:39 EDTICEIntercontinentalExchange sees returning nearly $1.7B to holders in 2014/15
Subscribe for More Information
08:33 EDTICEIntercontinentalExchange says Q2 volume impacted by low volatility
Subscribe for More Information
08:16 EDTSTJSt. Jude Medical completes acquisition of NeuroTherm
Subscribe for More Information
07:45 EDTICEIntercontinentalExchange acquires trading technology patents
Subscribe for More Information
07:37 EDTCTLCenturyLink price target raised to $42-$44 from $37-$39 at Wells Fargo
Wells Fargo hiked its price target on CenturyLink after the company reported stronger than expected results. The firm thinks the company's results were solid, and it is upbeat about its free cash flow outlook. The firm keeps an Outperform rating on the shares.
07:35 EDTICEIntercontinentalExchange sees FY14 operating expenses $1.55B-$1.56B
For the full year 2014, operating expenses are expected to be $1.55B-$1.56B. The expense guidance is net of acquisition-related transaction and integration costs for all periods. ICE expects operational capital expenditures and capitalized softwarefor the full year 2014 in the range of $165M-$175M. ICE expects capital expenditures related to real estate to be $75M-$85M for the full year of 2014.
07:34 EDTICEIntercontinentalExchange sees Q3 operating expenses $390M-$395M
ICE expects operational capital expenditures and capitalized software in the range of $40M-$45M for Q3. ICE expects interest expense in the range of $23M-$24M for Q3 and Q4.
07:32 EDTICEIntercontinentalExchange reports Q2 adjusted EPS $2.10, consensus $2.02
Subscribe for More Information
06:52 EDTLINELINN Energy raises FY14 production to 1,217-1,268 MMcfe/d
The company's previous FY14 production was 1,075-1,135 MMcfe/d; The company expects to fully cover its distribution and generate excess of net cash provided by operating activities after distributions to unitholders and discretionary adjustments of approximately $63 million for the third quarter 2014 and $103 million for the full-year 2014.
06:52 EDTLINELINN Energy sees Q3 production to average 1,210-1,260 MMcfe/d
Subscribe for More Information
06:52 EDTLINELINN Energy reports Q2 average daily production up 2.4% to 1,131 MMcfe/d
Subscribe for More Information
06:52 EDTLINELINN Energy reports Q2 EPS (64c), may not be comparable consensus 42c
Reports Q2 revenue, consensus $954.79M; Q2 EPS of (64c) includes reduction of put option premium value over time, of approximately $393 million, or $1.20 per unit.
06:18 EDTGMGM issues recall for certain model year SAABs, Trailblazer EXTs, others
Subscribe for More Information
06:00 EDTGOLDRandgold Resources reports Q2 EPS 57c vs. 50c last year
Subscribe for More Information
05:51 EDTGOLDRandgold Resources provides update on Loulo-Gounkoto complex
Another record production quarter from its flagship Loulo-Gounkoto complex in Mali has set Randgold Resources up at the halfway mark to achieve its guidance for the year. At the same time, the developing Kibali mine in the Democratic Republic of Congo remained on track to reach its forecast target despite commissioning disruptions. Group gold production of 277,283 ounces for Q2 was down 2% on Q1's record output but 41% ahead of last year's corresponding quarter. Cost per ounce rose by 2% to $701 on the previous quarter but was 12% down on Q2 in 2013. Profit from mining of $162.3M decreased by 5% from the previous quarter but was up 54% on the corresponding quarter in 2013. Loulo-Gounkoto produced 174 052 ounces, up 3% on Q1, and the third quarter in a row that the complex has posted a record production number. In other significant developments, the paste backfill plant at the Yalea underground mine was commissioned, enabling miners to harvest almost 100% of the high grade zones. The complex's energy cost reduction programme continued to evolve with the installation of two more medium speed generators, due for commissioning in the second half of the year, capable of running on less expensive heavy fuel oil.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use